---
title: "Type 2 Diabetes, Obesity, and Metabolic Syndrome Linked to Lower Patient-Reported Response to Aero"
id: "pubmed-42952036"
canonical_url: "https://medichelpline.com/clinical-feed/pubmed-42952036"
content_type: "clinical_feed_article"
specialty: "Pharmacology"
source_name: "PubMed / NCBI"
source_url: "https://pubmed.ncbi.nlm.nih.gov/42952036/"
doi: "10.2500/aap.2026.47.260068"
published_at: "2026-11-01T00:00:00.000Z"
evidence_level: "Journal Article"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Type 2 Diabetes, Obesity, and Metabolic Syndrome Linked to Lower Patient-Reported Response to Aero
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pubmed-42952036
- **Specialty:** [Pharmacology](https://medichelpline.com/clinical-feed/pharmacology.md)
- **Primary Source:** PubMed / NCBI
- **Source URL:** [Original Journal Publication](https://pubmed.ncbi.nlm.nih.gov/42952036/)
- **DOI:** [10.2500/aap.2026.47.260068](https://doi.org/10.2500%2Faap.2026.47.260068)
- **Published At:** 2026-11-01T00:00:00.000Z
- **Evidence Rating:** Journal Article
## Executive GIST (TL;DR)
- Observational cross-sectional study of adults receiving **subcutaneous immunotherapy** (SCIT) at Montefiore Medical Center between July and September 2024. - Investigators assessed patient-reported response using visual analog scale scores for overall allergic rhinitis (AR) symptoms, nasal congestion, rhinorrhea, and ocular symptoms. - The cohort comprised 95 patients; mean age 51 ± 16 years; 71% female. Twenty-five (26%) had **type 2 diabetes**, 53 (56%) met criteria for **obesity** (BMI ≥30 kg/m²), and 27 (28%) had **metabolic syndrome**. - Across the entire group, reported improvement rates while on SCIT were: 67% overall AR symptoms, 72% nasal congestion, 67% rhinorrhea, and 63% ocular symptoms. - **Type 2 diabetes** associated with reduced odds of overall symptom improvement (OR 0.23; 95% CI 0.06–0.89; p = 0.037), according to the authors. - **Metabolic syndrome** associated with lower odds of improvement in overall AR symptoms (OR 0.21; 95% CI 0.03–0.61; p = 0.010), nasal congestion (OR 0.24; 95% CI 0.06–0.88; p = 0.036), and rhinorrhea (OR 0.22; 95% CI 0.06–0.75; p = 0.019). - Use of metformin, insulin, sulfonylureas, or GLP-1 receptor agonists did not significantly affect reported SCIT response; the authors reported no significant medication effects. - Investigators concluded that **type 2 diabetes** and **metabolic syndrome** may identify a subgroup with lower improvement after SCIT and recommended prospective studies to determine predictive value. - The source did not report detailed SCIT dosing regimens, duration of treatment per patient, or objective clinical endpoints beyond self-reported visual analog scales.
## Clinical Analysis & Structured Key Points
Clipboard, Search History, and several other advanced features are temporarily unavailable. [ Skip to main page content ](https://pubmed.ncbi.nlm.nih.gov/42952036/#article-details) ### NIH Websites Are Changing * [Get the Latest Updates and FAQs on the transition](https://www.nih.gov/web-modernization) * Per [Executive Order 14434](https://www.whitehouse.gov/presidential-actions/2026/09/inaugurating-the-era-of-super-intelligence/), federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition. ![U.S. flag](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png) An official website of the United States government Here's how you know ![Dot gov](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg) **The .gov means it’s official.** Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. ![Https](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg) **The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. [ ![NIH NLM Logo](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg) ](https://www.ncbi.nlm.nih.gov/) [Log in](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42952036%2F) Show account info Close #### Account Logged in as: **username** * [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/) * [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/) * [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/) * [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A//pubmed.ncbi.nlm.nih.gov/42952036/) [Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys) [NCBI Homepage](https://www.ncbi.nlm.nih.gov) [MyNCBI Homepage](https://pubmed.ncbi.nlm.nih.gov/myncbi/) [Main Content](https://pubmed.ncbi.nlm.nih.gov/42952036/#maincontent) [Main Navigation](https://pubmed.ncbi.nlm.nih.gov/42952036/) [ ![pubmed logo](https://cdn.ncbi.nlm.nih.gov/pubmed/a447896c-976f-490b-b86b-2668b65114a8/core/images/pubmed-logo-blue.svg) ](https://pubmed.ncbi.nlm.nih.gov/) [ ](https://pubmed.ncbi.nlm.nih.gov/42952036/ "Show search bar") Search: [](https://pubmed.ncbi.nlm.nih.gov/42952036/ "Clear search input")Search [Advanced](https://pubmed.ncbi.nlm.nih.gov/advanced/) [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/clipboard/) [ User Guide ](https://pubmed.ncbi.nlm.nih.gov/help/) Save Email Send to * [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/42952036/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42952036%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42952036%2F%23open-collections-panel) * [Citation manager](https://pubmed.ncbi.nlm.nih.gov/42952036/) Display options Display options Format Abstract PubMed PMID ## Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel ## Email citation Email address has not been verified. Go to [ My NCBI account settings ](https://account.ncbi.nlm.nih.gov/settings/) to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel ### Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42952036/) Add Cancel ### Add to My Bibliography * My Bibliography Unable to load your delegates due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42952036/) Add Cancel ## Your saved search Name of saved search: Search terms: [Test search terms](https://pubmed.ncbi.nlm.nih.gov/42952036/) Would you like email updates of new search results? Saved Search Alert Radio Buttons * Yes * No Email: ([change](https://www.ncbi.nlm.nih.gov/account/settings/)) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel ## Create a file for external citation management software Create file Cancel ## Your RSS Feed Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy ### Full text links [![Ingenta plc full text link](https://cdn.ncbi.nlm.nih.gov/corehtml/query/egifs/https:--www.ingentaconnect.com-images-ingenta-connect.png) Ingenta plc ](https://www.ingentaconnect.com/openurl?genre=article&issn=&volume=47&issue=6&spage=405&aulast=Capellan%20Durante "See full text options at Ingenta plc") [ Full text links ](https://pubmed.ncbi.nlm.nih.gov/42952036/) ### Actions Cite Collections Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42952036/) Add Cancel Permalink Permalink Copy Display options Display options Format Abstract PubMed PMID ### Experimental Resource Linked Discoveries ### Page navigation * [ Title & authors ](https://pubmed.ncbi.nlm.nih.gov/42952036/#heading) * [ Abstract ](https://pubmed.ncbi.nlm.nih.gov/42952036/#abstract) * [ Publication types ](https://pubmed.ncbi.nlm.nih.gov/42952036/#publication-types) * [ MeSH terms ](https://pubmed.ncbi.nlm.nih.gov/42952036/#mesh-terms) * [ Substances ](https://pubmed.ncbi.nlm.nih.gov/42952036/#substances) * [Related information](https://pubmed.ncbi.nlm.nih.gov/42952036/#related-links) * [ LinkOut - more resources ](https://pubmed.ncbi.nlm.nih.gov/42952036/#linkout) Title & authors Abstract Publication types MeSH terms Substances Related information LinkOut - more resources Observational Study Allergy Asthma Proc Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Allergy+Asthma+Proc%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Allergy+Asthma+Proc%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42952036/) . 2026 Nov 1;47(6):405-413. doi: 10.2500/aap.2026.47.260068. # Association of type 2 diabetes, obesity, and metabolic syndrome with patient-reported response to aeroallergen subcutaneous immunotherapy: A real-world cross-sectional study [Evelyn Capellan Durante](https://pubmed.ncbi.nlm.nih.gov/?term=Capellan+Durante+E&cauthor_id=42952036)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42952036/#full-view-affiliation-1 "From the Department of Medicine, Division of Allergy and Immunology, Montefiore Medical Center, Bronx, New York and."), [Isabelle Ilan](https://pubmed.ncbi.nlm.nih.gov/?term=Ilan+I&cauthor_id=42952036)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42952036/#full-view-affiliation-2 "Albert Einstein College of Medicine, Bronx, New York."), [Janet Choi](https://pubmed.ncbi.nlm.nih.gov/?term=Choi+J&cauthor_id=42952036)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42952036/#full-view-affiliation-2 "Albert Einstein College of Medicine, Bronx, New York."), [Jade Cohen](https://pubmed.ncbi.nlm.nih.gov/?term=Cohen+J&cauthor_id=42952036)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42952036/#full-view-affiliation-2 "Albert Einstein College of Medicine, Bronx, New York."), [Akhil Upad](https://pubmed.ncbi.nlm.nih.gov/?term=Upad+A&cauthor_id=42952036)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42952036/#full-view-affiliation-2 "Albert Einstein College of Medicine, Bronx, New York."), [Leeba Sullivan](https://pubmed.ncbi.nlm.nih.gov/?term=Sullivan+L&cauthor_id=42952036)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42952036/#full-view-affiliation-2 "Albert Einstein College of Medicine, Bronx, New York."), [Golda Hudes](https://pubmed.ncbi.nlm.nih.gov/?term=Hudes+G&cauthor_id=42952036)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42952036/#full-view-affiliation-1 "From the Department of Medicine, Division of Allergy and Immunology, Montefiore Medical Center, Bronx, New York and."), [Manish Ramesh](https://pubmed.ncbi.nlm.nih.gov/?term=Ramesh+M&cauthor_id=42952036)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42952036/#full-view-affiliation-1 "From the Department of Medicine, Division of Allergy and Immunology, Montefiore Medical Center, Bronx, New York and."), [Denisa Ferastraoaru](https://pubmed.ncbi.nlm.nih.gov/?term=Ferastraoaru+D&cauthor_id=42952036)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42952036/#full-view-affiliation-1 "From the Department of Medicine, Division of Allergy and Immunology, Montefiore Medical Center, Bronx, New York and.") Affiliations Expand ### Affiliations * 1 From the Department of Medicine, Division of Allergy and Immunology, Montefiore Medical Center, Bronx, New York and. * 2 Albert Einstein College of Medicine, Bronx, New York. * PMID: **42952036** * DOI: [ 10.2500/aap.2026.47.260068 ](https://doi.org/10.2500/aap.2026.47.260068) Item in Clipboard Observational Study # Association of type 2 diabetes, obesity, and metabolic syndrome with patient-reported response to aeroallergen subcutaneous immunotherapy: A real-world cross-sectional study Evelyn Capellan Durante et al. Allergy Asthma Proc. 2026. Show details Display options Display options Format Abstract PubMed PMID Allergy Asthma Proc Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Allergy+Asthma+Proc%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Allergy+Asthma+Proc%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42952036/) . 2026 Nov 1;47(6):405-413. doi: 10.2500/aap.2026.47.260068. ### Authors [Evelyn Capellan Durante](https://pubmed.ncbi.nlm.nih.gov/?term=Capellan+Durante+E&cauthor_id=42952036)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42952036/#short-view-affiliation-1 "From the Department of Medicine, Division of Allergy and Immunology, Montefiore Medical Center, Bronx, New York and."), [Isabelle Ilan](https://pubmed.ncbi.nlm.nih.gov/?term=Ilan+I&cauthor_id=42952036)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42952036/#short-view-affiliation-2 "Albert Einstein College of Medicine, Bronx, New York."), [Janet Choi](https://pubmed.ncbi.nlm.nih.gov/?term=Choi+J&cauthor_id=42952036)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42952036/#short-view-affiliation-2 "Albert Einstein College of Medicine, Bronx, New York."), [Jade Cohen](https://pubmed.ncbi.nlm.nih.gov/?term=Cohen+J&cauthor_id=42952036)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42952036/#short-view-affiliation-2 "Albert Einstein College of Medicine, Bronx, New York."), [Akhil Upad](https://pubmed.ncbi.nlm.nih.gov/?term=Upad+A&cauthor_id=42952036)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42952036/#short-view-affiliation-2 "Albert Einstein College of Medicine, Bronx, New York."), [Leeba Sullivan](https://pubmed.ncbi.nlm.nih.gov/?term=Sullivan+L&cauthor_id=42952036)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42952036/#short-view-affiliation-2 "Albert Einstein College of Medicine, Bronx, New York."), [Golda Hudes](https://pubmed.ncbi.nlm.nih.gov/?term=Hudes+G&cauthor_id=42952036)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42952036/#short-view-affiliation-1 "From the Department of Medicine, Division of Allergy and Immunology, Montefiore Medical Center, Bronx, New York and."), [Manish Ramesh](https://pubmed.ncbi.nlm.nih.gov/?term=Ramesh+M&cauthor_id=42952036)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42952036/#short-view-affiliation-1 "From the Department of Medicine, Division of Allergy and Immunology, Montefiore Medical Center, Bronx, New York and."), [Denisa Ferastraoaru](https://pubmed.ncbi.nlm.nih.gov/?term=Ferastraoaru+D&cauthor_id=42952036)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42952036/#short-view-affiliation-1 "From the Department of Medicine, Division of Allergy and Immunology, Montefiore Medical Center, Bronx, New York and.") ### Affiliations * 1 From the Department of Medicine, Division of Allergy and Immunology, Montefiore Medical Center, Bronx, New York and. * 2 Albert Einstein College of Medicine, Bronx, New York. * PMID: **42952036** * DOI: [ 10.2500/aap.2026.47.260068 ](https://doi.org/10.2500/aap.2026.47.260068) Item in Clipboard Full text links Cite Display options Display options Format Abstract PubMed PMID Linked Discoveries ## Abstract **Background:** Although recent studies have examined the impact of metabolic diseases on the immune system, limited data exist on how these conditions and their treatments affect therapeutic approaches for atopic diseases, including subcutaneous immunotherapy (SCIT). **Objective:** The objective was to evaluate the association of type 2 diabetes mellitus (T2DM), obesity, metabolic syndrome, and patient-reported clinical response to SCIT in a real-world setting. **Methods:** We conducted an observational cross-sectional study of adults receiving SCIT at Montefiore Medical Center, Bronx, New York, between July and September 2024. The SCIT response was assessed by using visual analog scale scores for overall allergic rhinitis (AR) symptoms, nasal congestion, rhinorrhea, and ocular symptoms, stratified by T2DM, obesity (body mass index ≥ 30 kg/m²), and metabolic syndrome. **Results:** Overall, 95 patients were included, with a mean ± standard deviation age of 51 ± 16 years, the majority being women (71%). Twenty-five patients (26%) had T2DM, 53 (56%) were obese, and 27 (28%) had metabolic syndrome. In the entire cohort, 67% had improvement in overall AR symptoms with SCIT, 72% in nasal congestion, 67% in rhinorrhea, and 63% in ocular symptoms. T2DM was associated with significantly reduced odds of overall symptom improvement (odds ratio [OR] 0.23 [95% confidence interval {CI}, 0.06-0.89]; p = 0.037). The patients with metabolic syndrome had significantly lower odds of improvement in overall AR symptoms (OR 0.21 [95% CI, 0.03-0.61]; p = 0.010), nasal congestion (OR 0.24 [95% CI, 0.06-0.88]; p = 0.036), and rhinorrhea (OR 0.22 [95% CI, 0.06- 0.75]; p = 0.019) while on SCIT. Use of metformin, insulin, sulfonylureas, or glucagon-like peptide-1 receptor agonists did not significantly influence the SCIT response. **Conclusion:** T2DM and metabolic syndrome may identify a subgroup of patients with lower improvement after SCIT. Prospective studies are needed to determine whether metabolic disorders predict SCIT-associated responsiveness. [PubMed Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) ## Publication types * Observational Study Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Observational+Study%22%5Bpt%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Observational+Study) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42952036/) ## MeSH terms * Adult Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Adult%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Adult) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42952036/) * Aged Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Aged%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Aged) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42952036/) * Allergens* / immunology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Allergens%2Fimmunology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Allergens) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42952036/) * Cross-Sectional Studies Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Cross-Sectional+Studies%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Cross-Sectional+Studies) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42952036/) * Desensitization, Immunologic* / methods Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Desensitization%2C+Immunologic%2Fmethods%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Desensitization%2C+Immunologic) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42952036/) * Diabetes Mellitus, Type 2* / complications Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Diabetes+Mellitus%2C+Type+2%2Fcomplications%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Diabetes+Mellitus%2C+Type+2) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42952036/) * Diabetes Mellitus, Type 2* / epidemiology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Diabetes+Mellitus%2C+Type+2%2Fepidemiology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Diabetes+Mellitus%2C+Type+2) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42952036/) * Diabetes Mellitus, Type 2* / immunology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Diabetes+Mellitus%2C+Type+2%2Fimmunology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Diabetes+Mellitus%2C+Type+2) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42952036/) * Female Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Female%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Female) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42952036/) * Humans Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Humans%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Humans) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42952036/) * Injections, Subcutaneous Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Injections%2C+Subcutaneous%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Injections%2C+Subcutaneous) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42952036/) * Male Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Male%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Male) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42952036/) * Metabolic Syndrome* / complications Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Metabolic+Syndrome%2Fcomplications%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Metabolic+Syndrome) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42952036/) * Metabolic Syndrome* / epidemiology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Metabolic+Syndrome%2Fepidemiology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Metabolic+Syndrome)
## Related Clinical Research

- [GLP-1 receptor agonists and PMOS: evidence, mechanisms, and who may benefit](https://medichelpline.com/clinical-feed/medical-news-today-0-can-glp-1s-really-help-treat-pmos-experts-answer-3-key-questions.md)
- [Lifestyle Changes May Help Prevent Multimorbidity In Prediabetes](https://medichelpline.com/clinical-feed/medical-news-today-23-diet-weight-loss-and-150-minutes-of-exercise-may-protect-against-chronic.md)
- [Metformin reduces metabolic and oxidative changes in a high-sucrose Drosophila model](https://medichelpline.com/clinical-feed/plos-one-13-metformin-modulates-survival-oxidative-stress-and-gene-expression-in-a-high.md)
- [Gut–pancreatic peptide therapies in metabolic disease: from GLP-1 mono-agonists to multi-agonist s](https://medichelpline.com/clinical-feed/pubmed-42307179.md) (DOI: 10.1042/BSR20250114)
- [Orforglipron Added to Titrated Insulin Glargine Improves Glycemic Control and Weight in Type 2 Dia](https://medichelpline.com/clinical-feed/pubmed-42251769.md) (DOI: 10.1001/jama.2026.9512)

## Navigation
- [← Back to Pharmacology Feed](https://medichelpline.com/clinical-feed/pharmacology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.